Metabolism and Body Shape of Healthy Children and Children With Chronic Infections
HIV Infections, Healthy, Hyperlipidemia
About this trial
This is an observational trial for HIV Infections focused on measuring Body Fat, DXA, HAART, Hyperlipidemia, Insulin Resistance, Lipodystrophy, MRI, Protease Inhibitor, Side-Effects, Visceral Fat, Chronic Infection, HIV, Healthy Volunteer
Eligibility Criteria
FOR PROTEASE INHIBITOR-NAIVE HIV-INFECTED CHILDREN AND HIV-INFECTED CHILDREN ON PROTEASE INHIBITOR-CONTAINING ANTIRETROVIRAL REGIMENS: Evidence of HIV infection based on Center for Disease Control and Prevention criteria. Enrollment on protocol 98-C-0041 or other HIV treatment protocol for children. No other chronic disease unrelated to infection that may cause changes in body composition or in lipid or glucose homeostasis. No previous use of a protease inhibitor-containing antiretroviral regimen (PROTEASE INHIBITOR-NAIVE HIV-INFECTED CHILDREN ONLY). Data available concerning the start date of protease inhibitor treatment (HIV-INFECTED CHILDREN ON PROTEASE INHIBITOR-CONTAINING ANTIRETROVIRAL REGIMENS ONLY). HEALTHY PEDIATRIC VOLUNTEERS: Good general health. No significant hematologic, renal, hepatic, endocrinologic, or pulmonary disorders. No evidence of HIV infection by standard HIV antibody testing. Body mass index for age below 85th percentile. Not currently using prescription medications on a continuing basis; the use of over-the-counter medications will be reviewed on a case-by-case basis. Stable clinical condition during evaluation. CHILDREN WITH CONDITIONS CAUSING CHRONIC INFECTIONS OTHER THAN HIV: Evidence of chronic, non-HIV-related infection such as chronic granulomatous disease, hyperimmunoglobin E syndrome, etc. Evidence of non-growth hormone-deficient growth failure, defined as a 12-month height velocity at or below the fifth percentile for age using standard reference norms and by clinically-indicated testing. No evidence of HIV infection by standard HIV antibody testing. No current (last 2 months) use of sex steroid supplementation. Enrollment in an ongoing NIH protocol for treatment of their disorders. Age between 4 and 18 years. No other chronic disease unrelated to infection that may cause either changes in body composition or lipid or glucose homeostasis such as Type I diabetes mellitus, lipodystrophic diabetes, Cushing's syndrome etc. No pregnancy. No inability to undergo MRI because of metal objects within their bodies that are contraindications for MRI. These include cardiac pacemakers, neural pacemakers, aneurysmal clips, schrapnel, ocular foreign bodies, cochlear implants, non-detachable electronic or electromechanical devices. No allergic reaction to heparin.
Sites / Locations
- National Institute of Child Health and Human Development (NICHD)